Managed by NetworkPharma

Managed by

Facilitating Networking and Information Sharing amongst Pharmaceutical and MedComms, Medical Communications, Medical Education and Medical Publishing Specialists

This global initiative facilitates networking and dialogue amongst individuals working in and around the pharmaceutical industry and MedComms, focusing on specialist medical education, medical communications and medical publishing activities.
Why not sign up to our weekly newsletter and please, help spread the word amongst all relevant others.


  • Home
  • About us
  • Testimonials
  • Events
  • Useful Reading
  • In the News
  • Companies
  • Independents
  • Services
  • Training Room
  • Job Adverts
  • Twittering
  • Webcasts
  • Podcasts
  • Starting out
  • Weekly Newsletter
  • Weekly Comment
  • Survey data
  • Sponsors

  • MedComms Networking on Facebook

    MedComms Networking on Linkedin

    MedComms Networking on Twitter

    MedComms Networking on YouTube

    MedComms Networking is sponsored by:

    Many thanks to all the Sponsors of MedComms Networking


    Every Tuesday we send out the MedComms Networking email newsletter to subscribers. It includes brief commentary on what we're doing and planning, and highlights relevant news to encourage sharing of information, experiences and ideas and to stimulate discussion. The text and links included below, by definition, were accurate on the day of publication, but may then become outdated.

    MedComms Networking - 24 January 2023


    Last week's EXTRA #MedComms webinar was fun. Should we take notice of ChatGPT and allied AI technologies in MedComms? Gather your colleagues, share cake, stream the video and you decide.

    Someone described the webinar as being "rustic". I think they meant it affectionately. We jumped online and chatted informally. Kudos to Martin Delahunty (Inspiring STEM Consulting), Katja Martin (medtextpert), Stephen Mott (PharmAdvisor) and Avishek Pal (Novartis) for joining in. Only 10 days after announcing the event, we almost but not quite hit 1,000 registrations and welcomed 519 attendees on the day. That's huge for a #MedComms webinar.

    We ran out of time. We raised far more questions than answers. The amount of commentary shared in the accompanying chat box was overwhelming. We at least catalysed some discussion. My objective was to get more people playing with ChatGPT and thinking about what might happen. Remember, this is the worst that AI will be. There is much more out there and so much more coming fast.

    Like it or not, whatever the consequences (intended and unintended), we now need to embrace this technology, not ignore it. As has been widely quoted elsewhere; "AI will not steal your job. A person who is comfortable with using AI will!"

    On Friday, this appeared from WAME (world association of medical editors); WAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications.

    "Journals have begun to publish papers in which chatbots such as ChatGPT are shown as co-authors. The following WAME recommendations are intended to inform editors and help them develop policies regarding chatbots for their journals, to help authors understand how use of chatbots might be attributed in their work, and address the need for all journal editors to have access manuscript screening tools. In this rapidly evolving field, we expect these recommendations to evolve as well..."

    Can we expect more such statements from the likes of ISMPP (International Society for Medical Publication Professionals), European Medical Writers Association (EMWA), American Medical Writers Association (AMWA), Australasian Medical Writers Association (AMWA), Healthcare Communications Association (HCA), Medical Affairs Professional Society (MAPS) and others?

    I'm sure there's lots of excitable chatter about AI at the 2023 European Meeting of ISMPP today, in London - follow #ISMPPEurope2023

    Will writers now morph into expert content managers and editors to handle AI-generated text? Will Job Ads appear for "Prompt Engineers" in MedComms? What's Google's next move? The explosive interest has been helped, of course, by free access to ChatGPT. Rumours now abound around charges. Are there implications for inclusivity? Rich kids do homework in minutes using AI and poor kids watch? My social media feeds are already full of Ads for such paid-for services.

    This year maybe just got a lot more interesting.

    P.S. For better or worse, these words today are mine. I didn't like what ChatGPT did when I asked it to help! You may well have disagreed.

    There's lots more coming. Stay well, everyone. Keep the discussions going, using #MedComms.


    Peter Llewellyn
    Managing Director, NetworkPharma Ltd
    Follow me on LinkedIn @NetworkPharma
    Join more than 7,600 international colleagues in the MedComms Networking Linkedin Group
    The information at is always bang up-to-date!


    Subscribe to the weekly MedComms Networking email newsletter here - it's entirely free of charge!

    This web site and associated activities are being managed by NetworkPharma Ltd, Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, UK
    Telephone +44 (0) 1865 784390 Email: